Evidence map›Paper›PMID 32961983›Full record

ArticleInternational journal of molecular sciences2020

Prognostic Value of the Overexpression of Fatty Acid Metabolism-Related Enzymes in Squamous Cell Carcinoma of the Head and Neck.

Ying-Wen Su, Pao-Shu Wu, Sheng-Hsiang Lin, Wen-Yu Huang, Yu-Shao Kuo, Hung-Pin Lin

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. The Physiological and Pathological Role of Acyl-CoA Oxidation.International journal of molecular sciences · 2023
    Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Ying-Wen SuDivision of Hematology and Medical Oncology, Department of Internal Medicine, MacKay Memorial Hospital, Taipei 10449, Taiwan.
Pao-Shu WuDepartment of Pathology, MacKay Memorial Hospital, Tamsui Branch, New Taipei City 25160, Taiwan.ORCID 0000-0003-4823-9582
Sheng-Hsiang LinInstitute of Clinical Medicine and Department of Public Health, College of Medicine, National Cheng Kung University, Tainan 70101, Taiwan.
Wen-Yu HuangLaboratory of Good Clinical Research Center, MacKay Memorial Hospital, Tamsui Branch, New Taipei City 25160, Taiwan.
Yu-Shao KuoSchool of Chinese Medicine, China Medical University, Taichung 40402, Taiwan.
Hung-Pin LinMacKay Junior College of Medicine, Nursing, and Management, Taipei 25245, Taiwan.
Mackay Memorial Hospital · TWChina Medical University · TWNational Cheng Kung University Hospital · TW

Funding

Mackay Memorial Hospital MMH-108-78, MMH-106-94Ministry of Science and Technology, Taiwan MOST-108-2314-B-195-004
6 · The paper itself

Abstract

Reprogramming of cellular energy metabolism, such as lipid metabolism, is a hallmark of squamous cell carcinoma of the head and neck (SCCHN). However, whether protein expression related to fatty acid oxidation (FAO) affects survival in SCCHN remains unclear. We aimed to investigate FAO-related enzyme expression and determine its correlation with clinicopathological variables in SCCHN patients. Immunohistochemical analysis (IHC) of FAO-related protein expression, including carnitine palmitoyltransferase 1 (CPT1), the acyl-CoA dehydrogenase family, and fatty acid synthase (FAS), was performed using tissue microarrays from 102 resected SCCHN tumors. Expressions were categorized according to IHC scores, and the statistical association with clinicopathological factors was determined. Moderate-to-high expression of long-chain acyl-CoA dehydrogenase (LCAD) had a protective role against cancer-related death (adjusted hazard ratio (HR), 0.2; 95% confidence interval (CI), 0.05-0.87) after covariate adjustment. Age and clinical stage remained independent predictors of survival (adjusted HR, 1.75; 95% CI, 1.22-2.49 for age; adjusted HR, 14.33; 95% CI, 1.89-108.60 for stage III/IV disease). Overexpression of medium-chain acyl-CoA dehydrogenase and FAS correlated with advanced tumor stage (T3/T4); however, none of these factors were independent predictors of survival. Several FAO-related enzymes were upregulated and LCAD overexpression had a protective effect on overall survival in advanced SCCHN patients. FAO-related-enzyme expression might have a prognostic impact on survival outcomes in SCCHN.

Indexed as

Acyl-CoA Dehydrogenase, Long-ChainAdultAgedAged, 80 and overCarnitine O-PalmitoyltransferaseFatty AcidsFatty Acid SynthasesFemaleHead and Neck NeoplasmsHumansImmunohistochemistryMaleMiddle AgedNeoplasm StagingPrognosisProportional Hazards ModelsAcyl-CoA Dehydrogenase, Long-ChainCarnitine O-PalmitoyltransferaseFatty AcidsFatty Acid Synthasesfatty acid metabolismhead and necklong-chain acyl-CoA dehydrogenasesquamous cell carcinoma

Identifiers

PMID32961983
PMCPMC7559281
OpenAlexW3087372038

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.